Evidence map›Paper›PMID 32714925›Full record

ArticleFrontiers in cell and developmental biology2020

MicroRNA-221 Modulates Airway Remodeling via the PI3K/AKT Pathway in OVA-Induced Chronic Murine Asthma.

Jing Pan, Qianyuan Yang, Yao Zhou, Huan Deng, Yifan Zhu, Deyu Zhao, Feng Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Connecting the Dots: How MicroRNAs Link Asthma and Atherosclerosis.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Article
  8. Noncoding RNAs in asthmatic airway smooth muscle cells.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  9. Experimental animal models of chronic inflammation.Current research in immunology · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Exploration of the Molecular Mechanisms ofBioMed research international · 2022
    Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jing PanDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.
Qianyuan YangDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.
Yao ZhouDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.
Huan DengDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.
Yifan ZhuDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.
Deyu ZhaoDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.
Feng LiuDepartment of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing, China.
Second Affiliated Hospital of Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAirway remodeling is one of the most important pathological features of chronic asthma. This study aimed to determine whether microRNA-221 (hereafter, miR-221) can affect airway remodeling in a mouse model of ovalbumin (OVA)-induced chronic asthma.

methodsAdeno-associated viruses (AAVs) "Bearing miR-221 sponges" were used to downregulate miR-221 in asthmatic mice. Staining with hematoxylin and eosin (H&E), Masson trichrome, and periodic acid-Schiff reagent was used to assess histological changes. The affected signaling pathway in mouse airway smooth muscle cells (ASMCs) was also identified by gene chip technology. A PI3K/AKT-inhibitor (LY294002) was used to confirm the role of the pathway in ASMCs.

resultsThe inhibition of miR-221 in a murine asthma model was found to reduce airway hyper-responsiveness, mucus metaplasia, airway inflammation, and airway remodeling (

conclusionmiR-221 might play a crucial role in the mechanism of remodeling via the PI3K/AKT pathway in chronic asthma and it could be considered as a potential target for developing therapeutic strategies.

Indexed as

airway inflammationairway remodelingASMCsasthmamiR-221

Identifiers

PMID32714925
PMCPMC7344209
OpenAlexW3038212657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.